Home / Inspections / 1045293

FDA Inspection 1045293 — Reproductive Medicine Institute

Reproductive Medicine Institute — FEI 3009382995

The FDA completed an inspection of Reproductive Medicine Institute on February 8, 2018 in Bloomingdale, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 8, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Bloomingdale, IL (United States)

Facility

Other inspections at this facility

  • 1122259 (NAI Wed Feb 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 960979 (NAI Wed Jan 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 813531 (VAI Fri Jan 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources